633 related articles for article (PubMed ID: 19880569)
41. Systemic lupus erythematosus and pregnancy.
Molad Y
Curr Opin Obstet Gynecol; 2006 Dec; 18(6):613-7. PubMed ID: 17099331
[TBL] [Abstract][Full Text] [Related]
42. Clinical manifestations of systemic lupus erythematosus, measures of disease activity, and long-term complications.
Ginzler EM; Antoniadis I
Curr Opin Rheumatol; 1992 Oct; 4(5):672-80. PubMed ID: 1419501
[TBL] [Abstract][Full Text] [Related]
43. [Anti-U1RNP antibodies and lupus nephritis].
Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
[TBL] [Abstract][Full Text] [Related]
44. Oral manifestation of systemic lupus erythematosus: lupus nephritis--report of a case.
Sverzut AT; Allais M; Mazzonetto R; de Moraes M; Passeri LA; Moreira RW
Gen Dent; 2008; 56(1):35-41. PubMed ID: 18254558
[TBL] [Abstract][Full Text] [Related]
45. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
46. Systemic lupus erythematosus and vaccination.
Millet A; Decaux O; Perlat A; Grosbois B; Jego P
Eur J Intern Med; 2009 May; 20(3):236-41. PubMed ID: 19393490
[TBL] [Abstract][Full Text] [Related]
47. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
48. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Aringer M; Graninger WB; Steiner G; Smolen JS
Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
[TBL] [Abstract][Full Text] [Related]
49. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
50. Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus.
Bragazzi NL; Watad A; Sharif K; Adawi M; Aljadeff G; Amital H; Shoenfeld Y
Expert Rev Clin Immunol; 2017 Oct; 13(10):939-949. PubMed ID: 28749245
[TBL] [Abstract][Full Text] [Related]
51. [Physiopathology and therapy of systemic lupus erythematosus].
Kashiwagi H
Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):407-11. PubMed ID: 9577566
[No Abstract] [Full Text] [Related]
52. JAK2 inhibition in murine systemic lupus erythematosus.
Tagoe C; Putterman C
Immunotherapy; 2012 Apr; 4(4):369-72. PubMed ID: 22512630
[TBL] [Abstract][Full Text] [Related]
53. Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50.
Touma Z; Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2011 Feb; 38(2):275-84. PubMed ID: 21123323
[TBL] [Abstract][Full Text] [Related]
54. Steroid therapy in clinically stable but serologically active systemic lupus erythematosus prevents severe disease flares.
Cardiel MH; Almagro RM
Expert Rev Clin Immunol; 2007 May; 3(3):267-9. PubMed ID: 20477670
[TBL] [Abstract][Full Text] [Related]
55. Influenzal vaccine response in systemic lupus erythematosus.
Brodman R; Gilfillan R; Glass D; Schur PH
Ann Intern Med; 1978 Jun; 88(6):735-40. PubMed ID: 307353
[TBL] [Abstract][Full Text] [Related]
56. Recommendations and barriers to vaccination in systemic lupus erythematosus.
Garg M; Mufti N; Palmore TN; Hasni SA
Autoimmun Rev; 2018 Oct; 17(10):990-1001. PubMed ID: 30103044
[TBL] [Abstract][Full Text] [Related]
57. Influenza Vaccination in Systemic Lupus Erythematosus: Efficacy, Effectiveness, Safety, Utilization, and Barriers.
Sim JJL; Lim CC
Am J Med; 2022 Mar; 135(3):286-296.e9. PubMed ID: 34563493
[TBL] [Abstract][Full Text] [Related]
58. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety.
O'Neill SG; Isenberg DA
Lupus; 2006; 15(11):778-83. PubMed ID: 17153850
[TBL] [Abstract][Full Text] [Related]
59. Instruments to measure disease activity in systemic lupus erythematosus -- is our net tight enough to catch the hydra?
Sturfelt G; Nived O
J Rheumatol; 2011 Jan; 38(1):3-4. PubMed ID: 21196581
[No Abstract] [Full Text] [Related]
60. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination.
Zavala-Miranda MF; González-Ibarra SG; Pérez-Arias AA; Uribe-Uribe NO; Mejia-Vilet JM
Kidney Int; 2021 Dec; 100(6):1340-1341. PubMed ID: 34560139
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
